Through the Inherited Metabolic Diseases (IMD) Program, the Ministry of Health and Long-Term Care covers the full cost of certain outpatient drugs, supplements and specialty foods used in the treatment of specific inherited metabolic disorders. The IMD Program covers:

• Specific drugs and supplements
• Modified L-Amino Acid mixtures (“medical foods”)
• Special Low Protein Foods
• Other supplements
• Infant Feeds
• Complete Enteral Feeds

The IMD Program will cover the costs of the foregoing types of products (“Funded Products”), provided that the patient :

• Is an Ontario resident with valid Ontario Health Insurance (OHIP); 
• Has been diagnosed with an inherited metabolic disorder for which one of the Funded Products has been prescribed as a treatment;
• Is under the care of a physician from a designated treatment centre;
• Obtains the Funded Products from a designated treatment centre.

To register a patient in the IMD Program, an application and consent form must be completed and submitted to the ministry.

For further information on the reimbursement of Elaprase (idursulfase) for the treatment of Hunter's Syndrome, please see the following link for additional information: www.health.gov.on.ca/english/providers/program/drugs/pdf/elaprase_reimburse.pdf.

Inquiries regarding the IMD Program should be directed to :

Ontario Public Drug Programs
5700 Yonge Street, 3^rd Floor
Toronto ON  M2M 4K5
Tel.:416-327-8109
Fax: 416-327-8123
Email: PublicDrugPrgrms.moh@ontario.ca